CTOs on the Move

Cache Valley Specialty Hospital

www.cvsh.com

 
Cache Valley Specialty Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Cache Valley Specialty Hospital is based in Logan, UT. You can find more information on Cache Valley Specialty Hospital at www.cvsh.com
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cvsh.com
  • 2380 N 400 E
    Logan, UT USA 84341
  • Phone: 435.713.9700

Executives

Name Title Contact Details

Similar Companies

HCA Florida JFK Hospital

JFK Medical Center is now HCA Florida JFK Hospital. We offer cost-effective and high-quality care to South Florida. We are a 558-bed acute care medical and surgical facility with state-of-the-art equipment to accommodate the needs of all patients. For more than 50 years, we have provided a wide range of specialties to Palm Beach County including mental health and wellness, emergency care, sleep disorders, women`s care and orthopedic care. We are committed to research and the advancements of technology to bring the best tools and procedures to our patients. Visit our website to learn more about our hospital.

Burke County Hospital Auxiliary, Inc

Burke County Hospital Auxiliary, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waynesboro, GA. To find more information about Burke County Hospital Auxiliary, Inc, please visit www.burkemedical.net

Peppy

Peppy is the digital health health app that supports menopause, fertility, mens health, womens health and more with real health experts.

Owl Insights

Transforming Behavioral Health Care with Data, Evidence and Insights. Owl Insights is the leading provider of precision-guided behavioral health (BH) care management technology.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.